IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
WINTER SPRINGS, Fla., Feb. 08, 2024 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (the “Company”) (NASDAQ:IRMD) announced today its financial results for the three months and year ended December 31, 2023. The Company is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system, and non-magnetic patient vital signs monitoring systems that are designed for use during MRI procedures.
Related news for (IRMD)
- IRADIMED CORPORATION Announces FDA 510(k) Clearance for MRidium® 3870 Infusion Pump System
- IRADIMED CORPORATION Announces First Quarter 2025 Financial Results
- IRADIMED CORPORATION Announces Fourth Quarter and Full Year of 2024 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.17 Per Share from $0.15 Per Share
- IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 Revenues
- IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference